pms-Pyrazinamide en es it fr

pms-Pyrazinamide Brand names, pms-Pyrazinamide Analogs

pms-Pyrazinamide Brand Names Mixture

  • No information avaliable

pms-Pyrazinamide Chemical_Formula

C43H51N3O11

pms-Pyrazinamide RX_link

http://www.rxlist.com/cgi/generic/xifaxan.htm

pms-Pyrazinamide fda sheet

pms-Pyrazinamide FDA

pms-Pyrazinamide msds (material safety sheet)

pms-Pyrazinamide MSDS

pms-Pyrazinamide Synthesis Reference

No information avaliable

pms-Pyrazinamide Molecular Weight

785.879 g/mol

pms-Pyrazinamide Melting Point

No information avaliable

pms-Pyrazinamide H2O Solubility

No information avaliable

pms-Pyrazinamide State

No information avaliable

pms-Pyrazinamide LogP

4.161

pms-Pyrazinamide Dosage Forms

No information avaliable

pms-Pyrazinamide Indication

For the treatment of patients (>=12 years of age) with travelers' diarrhea caused by noninvasive strains of Escherichia coli.

pms-Pyrazinamide Pharmacology

Rifaximin is a structural analog of rifampin and non-systemic, gastrointestinal site-specific antibiotic. Rifaximin acts by inhibiting bacterial ribonucleic acid (RNA) synthesis. While an increase in pulmonary hydrogen excretion is evident in diverticular disease, the therapeutic effect of rifaximin does not appear to be due to a persistent correction of this alteration and the drug appears to cause no significant imbalance in the intestinal ecosystem.

pms-Pyrazinamide Absorption

Low absorption in both the fasting state and when administered within 30 minutes of a high-fat breakfast.

pms-Pyrazinamide side effects and Toxicity

LD50 > 2 g/kg (orally, in rats)

pms-Pyrazinamide Patient Information

No information avaliable

pms-Pyrazinamide Organisms Affected

Enteric bacteria and eubacteria